¯

Alzheimer's Disease

Aug. 26, 2026

A novel smartphone-enabled platform employing a fluorescence-responsive tiny molecule as a probe offers a simple, cost-effective, and accessible approach for the detection of the Alzheimer's disease (AD) biomarker amyloid-β (Aβ).

About Alzheimer's disease:

  • It is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioural impairment.
    • Central to its pathology is the misfolding and aggregation of amyloid-β (Aβ), which self-assembles into fibrils and deposits as extracellular plaques that trigger neurotoxic cascades leading to synaptic dysfunction and neurodegeneration.
  • It is the most common cause of dementia, accounting for 60-80% of all dementia cases worldwide.
  • The disease disrupts communication between brain cells, leading to a decline in cognitive and functional abilities.
  • It usually affects people aged 65 years and over.
  • Cause: The exact cause of Alzheimer’s disease is not fully understood, but it is believed to be influenced by a combination of genetic, environmental, and lifestyle factors.
  • Treatment: There’s no cure for Alzheimer’s, but certain medications and therapies can help manage symptoms temporarily.

Latest Current Affairs

See All

Enquire Now